Document is current
Any future updates will be listed below
-
Authors
Beldi, Ghada
Khosravi, Maryam
Abdelgawad, Mohamed Essameldin
Salomon, Benoît L.
Uzan, Georges
Haouas, Houda
Naserian, Sina https://orcid.org/0000-0003-3604-8375
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR_15-RHUS60002, ANR_15-RHUS60002)
Carthage University, Ministry of higher Education and scientific Research (Bourse d'Alternance)
- License Information
-
More Information
Article History
Received: 28 January 2020
Revised: 30 April 2020
Accepted: 25 May 2020
First Online: 16 July 2020
Ethics approval and consent to participate
: All experimental procedures were performed in accordance with the European Community Council Directive (2010/63/UE) for the care and use of laboratory animals. Experimental protocols were approved by the local ethics committee “Comité d’éthique en expérimentation animal Charles Darwin No. 5” under the number 02811.03 in compliance with the European Union guidelines.
: Not applicable
: Sina Naserian, Ph.D., is the CEO of CellMedEx Company.The authors declare that they have no competing interests.
